RESEARCH-USE BIOSIMILAR ANTIBODY
Bempikibart
Monoclonal antibody · IgG1
Bempikibart (ADX-914) is a fully human anti-IL-7Rα antibody that re-regulates adaptive immune function by blocking signaling mediated by both IL-7 and thymic stromal lymphopoietin (TSLP). Bempikibart can be used for the study of atopic dermatitis and alopecia areata.
TARGETCD127
YMonoclonal antibody
CATALOGSC-BS-728
CATALOG NUMBERSC-BS-728
MOLECULAR WEIGHTApprox. 145.745 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Bempikibart (ADX-914) is a fully human anti-IL-7Rα antibody that re-regulates adaptive immune function by blocking signaling mediated by both IL-7 and thymic stromal lymphopoietin (TSLP). Bempikibart can be used for the study of atopic dermatitis and alopecia areata.
Bempikibart is a recombinant research-use antibody directed against CD127.